Global News

LabConnect expanding advanced laboratory operations center in Tennessee

Wednesday, April 8, 2015 12:54 PM

LabConnect, a global provider of central laboratory services, will be moving its operations center in Johnson City, Tenn., to a new, 42,000-square-foot custom-built facility effective May 7. LabConnect’s laboratory testing facility in Johnson City will remain in its current location.

More... »

Quest Diagnostics

CRISPR Therapeutics to establish R&D operations in Massachusetts

Wednesday, April 8, 2015 12:42 PM

CRISPR Therapeutics, a Switzerland-based biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines for serious human diseases, has appointed Bill Lundberg, M.D., to chief scientific officer to lead the company's development programs and to spearhead the creation of its R&D operations in Cambridge, Mass.

More... »


Arvinas, Merck to collaborate

Wednesday, April 8, 2015 12:41 PM

Arvinas, a New Haven, Conn.-based private biotechnology company creating a new class of drugs based on protein degradation, has formed a strategic collaboration with Merck in which Arvinas' novel PROTAC technology will be used to degrade target proteins to create novel therapeutics. The multi-year collaboration will encompass multiple disease targets across several therapeutic areas.

More... »

Report: 9 out of 10 pharma companies have dedicated health economics, outcomes research groups

Monday, April 6, 2015 12:00 PM

Dedicated health economics and outcomes research (HEOR) teams that develop data to demonstrate a cohesive value proposition to payers are a vital part of a successful managed markets strategy, according to a new report by life sciences intelligence firm Cutting Edge Information.

More... »

AMRI to shutter U.K. facility, lay off 62 workers

Monday, April 6, 2015 12:00 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has decided to close its Holywell, U.K., facility, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API) and intermediates.

More... »

Cannabics Pharmaceuticals, Technion Institute ink agreement

Monday, April 6, 2015 11:58 AM

Cannabics Pharmaceuticals, based in Bethesda, Md., has inked a research agreement with the Israel Institute of Technology (Technion) in Israel, for the screening of potential anticancer cannabinoid compounds.

More... »

GSK to establish global vaccines R&D center in the U.S.

Monday, April 6, 2015 11:57 AM

GlaxoSmithKline is establishing a new global center for vaccines R&D in Rockville, Md. The site will become one of three global vaccines R&D centers for GSK, complementing the company’s existing global R&D center in Rixensart, Belgium and in Siena, Italy, a site GSK acquired from Novartis last month.

More... »

Adopting predictive analytics

Monday, April 6, 2015 08:00 AM

The 2008 financial crisis had a crippling effect on businesses operating within the financial sector.

More... »

Daiichi Sankyo, Asubio Pharmaceuticals to merge

Friday, April 3, 2015 01:41 PM

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Company, will merge with its U.S.-based sister company, Asubio Pharmaceuticals. As a result, Asubio Pharmaceuticals projects will be integrated into the Daiichi Sankyo global development organization, led by Mahmoud Ghazzi, M.D., Ph.D.

More... »

Sanofi, Schrödinger ink $120M drug design pact

Friday, April 3, 2015 01:39 PM

Schrödinger, a global provider of advanced molecular simulations and enterprise software solutions and services for life sciences and materials research, has entered into a collaboration with Sanofi in which Schrödinger will provide comprehensive computational drug design support, from target analysis and validation to lead identification and lead optimization, for as many as ten drug discovery programs. Schrödinger could receive up to $120 million under the terms of the broad, multi-year relationship that includes preclinical milestones.

More... »

`

CWWeekly

April 27

Doctors, patients in the U.S. and U.K. agree: Mobile health apps are good for our health

AARP teams with Georgia Tech's HomeLab, Pfizer and UnitedHealthcare to test wearables with consumers 50+

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs